Papers
33
Total Citations
501
H-Index
14
About
Riccardo Rizzetto is a urological surgeon and researcher whose work sits at the intersection of minimally invasive surgery, robotic-assisted oncology, and urologic cancer management. His research focuses predominantly on prostate cancer treatment, partial nephrectomy techniques, and the refinement of robotic surgical platforms, making him a notable contributor to contemporary uro-oncology. Among his most influential contributions is his participation in the multi-institutional RECORD 2 Project, comparing transperitoneal and retroperitoneal approaches in minimally invasive partial nephrectomy (51 citations), offering clinically actionable guidance for surgical planning. Rizzetto has also advanced understanding of pelvic lymph node dissection in prostate cancer, with landmark studies examining Cloquet's nodes and Marcille's fossa metastatic involvement (each garnering 30 citations), directly informing the extent of surgical lymphadenectomy. His work on body mass index as a predictor of serious surgical complications and obesity's role in lymph node metastasis highlights his interest in patient-specific risk stratification. Perhaps most distinctively, Rizzetto has led the prospective COMPAR-P trial, rigorously benchmarking the Hugo RAS against the da Vinci Xi robotic system across intraoperative performance and patient quality of life outcomes (36 and 23 citations respectively), positioning him as a forward-thinking evaluator of emerging surgical technologies. His cumulative citation record reflects meaningful and growing influence across the global urological surgery community.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10